Sapir Pharmaceuticals Inc. — Form D
Sapir Pharmaceuticals Inc. of NEW JERSEY, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2018-02-26. The offering totals $10.0M, of which $450K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-02-26
- Form: D
- Accession: 0001615774-18-001451
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $450K
- Remaining: $9.6M
- Minimum investment: $10K
- Investors: 4
- Date of first sale: 2017-08-16
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-306403
Issuer
- Name: Sapir Pharmaceuticals Inc.
- CIK: 0001732562
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 9 SHENANDOAH DRIVE, NEW JERSEY, NJ, 08701
- Phone: 347-407-3864
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Leonard Sternheim | Director | New York, NY |
| Samuel Sternheim | Director | Lakewood, NJ |
| Leonard Sternheim | Executive Officer | New York, NY |
| Samuel Sternheim | Executive Officer | Lakewood, NJ |
| Leonard Sternheim | Promoter | New York, NY |
| Samuel Sternheim | Promoter | Lakewood, NJ |
More